The updated NCCN Guidelines now include the recommendation for monoclonal antibodies for pre-exposure prophylaxis against COVID-19, highlighting the significance of Invivyd's products in cancer care.

Metastatic colorectal cancer (mCRC) remains a leading cause of cancer mortality worldwide. Conventional cytotoxic chemotherapy has formed the backbone of treatment, but advances in molecular oncology ...

What Impact Might the Data From the Phase 3 DESTINY-Breast09 Trial Have on Metastatic HER2-positive Breast Cancer Treatment? What Impact Might the Data From the Phase 3 APHINITY Trial Have on ...

The overuse of antibiotics is increasingly leading to the emergence of infectious superbugs—dangerous bacteria that have developed antimicrobial resistance (AMR) and are therefore much harder, if not ...

Diffuse Large B-Cell Lymphoma (DLBCL) is a type of blood cancer that that develops from B cell precursors. Healthy B cells produce a broad range of infection-fighting antibodies, making them ...

Two monoclonal antibody targeted therapies have been recommended for routine NHS use in England by the National Institute for Health and Care Excellence (NICE). Spesolimab (Spevigo, Boehringer ...

SINO BIOPHARMACEUTICAL (01177.HK) announced that Vetricotobat Monoclonal Antibody (CLDN18.2 ADC), a Class 1 innovative drug ...